Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015


Search Results for 'catalent'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »

Search Results:

Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
Published May 6, 2015
Oral Technologies drive growth in the quarter Read More »
Published May 6, 2015
Catalent Completes $52M Expansion at Winchester, KY, Facility Read More »
Defining Approaches and Best Practices for Quality Agreements
Published May 5, 2015
Scott Gunther of Catalent discusses critical issues with Quality Agreements, how best to address them, and key areas the FDA guidance will likely focus on.… Read More »
Published April 22, 2015
Expands advanced, aseptic, glass-free injectable platform Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Catalent Completes Winchester Expansion
Published April 15, 2015
Meets demands for advanced solid manufacturing Read More »
Published April 8, 2015
Cornell Stamoran elected to board of trustees Read More »
Consolidation in Outsourcing
By Michael A. Martorelli , Director, Fairmount Partners
Published March 6, 2015
Reviewing 2014’s M&A activity Read More »
Published February 27, 2015
Increases cold storage capabilities at three sites Read More »
Published February 12, 2015
Medication Delivery segment drives growth in the quarter Read More »
Published February 10, 2015
Castellano to lead investor relations efforts Read More »
By Brigitte de Lima, Results Healthcare
Published January 29, 2015
And thoughts on the year ahead. Read More »
Published January 15, 2015
Will apply Catalent’s SMARTag technology in Sanofi’s antibodies Read More »
Published January 7, 2015
Robinson and de Nobel bring extensive industry experience Read More »
Published December 4, 2014
Will support the development and reprofiling of zolpidem using Catalent’s OSDrC OptiDose Read More »
Published December 2, 2014
Catalent to provide cell line engineering, process development, and manufacturing Read More »
Published November 14, 2014
IPO costs impact results Read More »
Published November 14, 2014
Adds global particle size engineering technologies Read More »
Published November 3, 2014
Kansas City campus will be equipped with a new 6,000 sq. ft. facility. Read More »
Published October 28, 2014
Bisset succeeds Heyens Read More »
Published October 14, 2014
Fasman brings extensive experience in a broad range of industries Read More »
Preparing for the End
By Lonie Scott , Director of Clinical Business Development for North America, PCI
Published October 14, 2014
Keep sight of return logistics as you prepare for clinical trials. Read More »
Contamination Issues in Today’s Injectables Market
By Bill Hartzel , Director, Strategic Execution, Advanced Delivery Technologies
Published October 14, 2014
BFS technology drives advances in aseptic processing. Read More »
Published October 7, 2014
Flynn brings 28 years of experience Read More »
Published October 2, 2014
Further expands SMARTag Antibody-Drug Conjugate (ADC) technology platform Read More »
Published September 24, 2014
ADHD drugs will employ Catalent’s OSDrC OptiDose drug delivery platform Read More »
Staying Ahead of Regulatory Change
By Dan Pearce, Catalent Pharma Solutions
Published September 8, 2014
A rigorous system of regulatory intelligence and analysis is needed to manage changes, trends and observations in a global QMS Read More »
Published September 5, 2014
Oral Technologies revenue up 4% in the quarter Read More »
Published August 1, 2014
The drug delivery and development specialist went public yesterday, with shares now trading on the NYSE. Read More »
Studying Binding in BIosimilars
By Michael Sadick , Catalent
Published June 3, 2014
Bio-Layer Interferometry can be a useful addition to the orthogonal analysis toolkit required for characterizing biosimilars Read More »
Improving the Functional Characterization of Biosimilars
By Delana Butz, Ph.D., Manuela Grassi, Ph.D, Onesmo Mpanju, Ph.D., Duu-Gong Wu, Ph.D., Peter Wunderli, Ph.D. , PPD
Published June 3, 2014
New bioassay methods may help reduce the variability of analytical methods required to demonstrate comparability Read More »
Biopharma CMO Update
By William Downey , HighTech Business Decisions
Published June 3, 2014
Increased demand is driving higher capacity utilization and more partnerships Read More »
Published April 3, 2014
Kemwell expands lyophilization capacity Read More »
Published April 3, 2014
Catalent, CiRA in regenerative therapy pact Read More »
Published April 3, 2014
Catalent Pharma Solutions has increased its minority investment in Redwood Bioscience. The decision was based on data generated by the SMARTag ADC platform, a precision protein-chemical engineering platform and novel toxin-linker technology developed… Read More »
By Kristin Brooks
Published March 24, 2014
SMARTag ADC Technology achieves key milestone Read More »
By Kristin Brooks
Published March 11, 2014
To showcase new aseptic filling technology at INTERPHEX Read More »
Solid Dosage Outsourcing Trends
By Tom Spurgeon, Contract Pharma
Published March 7, 2014
CMOs look for technological, niche advantages Read More »
By Kristin Brooks
Published March 7, 2014
To manufacture mAb using GPEx technology for a clinical research project Read More »
By Kristin Brooks
Published February 3, 2014
Muir to lead all three of the company’s service offerings Read More »
By Andrew Badrot, CMS Pharma
Published January 30, 2014
DSM & Patheon unlock value through a creative merger Read More »
By Gil Roth
Published January 24, 2014
Looks to pay down debt with potential equity offering Read More »
By Kristin Brooks
Published January 24, 2014
Aims to accelerate research and drug delivery technologies Read More »
Integrated Services Providers
By Enrico Polastro, Arthur D. Little
Published January 22, 2014
A viable business model? Read More »
Consolidation in Outsourcing
By Michael A. Martorelli, Fairmount Partners
Published January 22, 2014
Reviewing 2013’s M&A activity Read More »
By Kristin Brooks
Published January 8, 2014
Catalent to manufacture ADS-5102 for Phase III trials Read More »
Published December 2, 2013
Catalent to provide capsules for ongoing trials and commercial supply Read More »
Published November 26, 2013
Keesee to lead site functions for clinical packaging and distribution facilities Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On